134 related articles for article (PubMed ID: 29359367)
21. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
[TBL] [Abstract][Full Text] [Related]
22. RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study.
Heerfordt IM; Philipsen PA; Andersen JD; Langhans L; Schmidt G; Morling N; Wulf HC
J Am Acad Dermatol; 2023 Sep; 89(3):537-543. PubMed ID: 37224970
[TBL] [Abstract][Full Text] [Related]
23. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
24. Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome Sequencing.
Artomov M; Stratigos AJ; Kim I; Kumar R; Lauss M; Reddy BY; Miao B; Daniela Robles-Espinoza C; Sankar A; Njauw CN; Shannon K; Gragoudas ES; Marie Lane A; Iyer V; Newton-Bishop JA; Timothy Bishop D; Holland EA; Mann GJ; Singh T; Daly MJ; Tsao H
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29522175
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M
BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811
[TBL] [Abstract][Full Text] [Related]
26. Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.
Liang X; Pfeiffer RM; Li WQ; Brossard M; Burke LS; Wheeler W; Calista D; Fargnoli MC; Ghiorzo P; Peris K; Bianchi-Scarra G; Chaudru V; Zelenika D; Maeder D; Burdette L; Yeager M; Chanock S; Landi MT; Demenais F; Tucker MA; Goldstein AM; Yang XR
J Invest Dermatol; 2014 Feb; 134(2):481-487. PubMed ID: 23892592
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer risk is not altered by TP53AIP1 germline mutations in a German case-control series.
Luedeke M; Coinac I; Linnert CM; Bogdanova N; Rinckleb AE; Schrader M; Vogel W; Hoegel J; Meyer A; Dörk T; Maier C
PLoS One; 2012; 7(3):e34128. PubMed ID: 22457820
[TBL] [Abstract][Full Text] [Related]
28. Comparison between familial and nonfamilial melanoma in France.
Grange F; Chompret A; Guilloud-Bataille M; Guillaume JC; Margulis A; Prade M; Demenais F; Avril MF
Arch Dermatol; 1995 Oct; 131(10):1154-9. PubMed ID: 7574832
[TBL] [Abstract][Full Text] [Related]
29. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
[TBL] [Abstract][Full Text] [Related]
30. [Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome].
Kharkevich GIu; Kazubskaia TP; Agapova RK; Musatov VK; Trubnikov VI; Demidov LV; Gar'kavtseva RF
Genetika; 1995 Nov; 31(11):1562-5. PubMed ID: 8666223
[TBL] [Abstract][Full Text] [Related]
31. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
[TBL] [Abstract][Full Text] [Related]
32. Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population.
Lamperska K; Karezewska A; Kwiatkowska E; Mackiewicz A
Acta Biochim Pol; 2002; 49(2):369-76. PubMed ID: 12362978
[TBL] [Abstract][Full Text] [Related]
33. Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.
Di Lucca J; Guedj M; Lacapère JJ; Fargnoli MC; Bourillon A; Dieudé P; Dupin N; Wolkenstein P; Aegerter P; Saiag P; Descamps V; Lebbe C; Basset-Seguin N; Peris K; Grandchamp B; Soufir N
Eur J Cancer; 2009 Dec; 45(18):3228-36. PubMed ID: 19477635
[TBL] [Abstract][Full Text] [Related]
34. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.
Howell WM; Turner SJ; Theaker JM; Bateman AC
Eur J Immunogenet; 2003 Dec; 30(6):409-14. PubMed ID: 14675394
[TBL] [Abstract][Full Text] [Related]
35. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
[TBL] [Abstract][Full Text] [Related]
36. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
Landi MT; Baccarelli A; Tarone RE; Pesatori A; Tucker MA; Hedayati M; Grossman L
J Natl Cancer Inst; 2002 Jan; 94(2):94-101. PubMed ID: 11792747
[TBL] [Abstract][Full Text] [Related]
37. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
Jönsson G; Bendahl PO; Sandberg T; Kurbasic A; Staaf J; Sunde L; Crüger DG; Ingvar C; Olsson H; Borg A
J Natl Cancer Inst; 2005 Sep; 97(18):1377-82. PubMed ID: 16174859
[TBL] [Abstract][Full Text] [Related]
38. Rare SF3B1 R625 mutations in cutaneous melanoma.
Kong Y; Krauthammer M; Halaban R
Melanoma Res; 2014 Aug; 24(4):332-4. PubMed ID: 24709888
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases.
Aoude LG; Gartside M; Johansson P; Palmer JM; Symmons J; Martin NG; Montgomery GW; Hayward NK
Twin Res Hum Genet; 2015 Apr; 18(2):126-33. PubMed ID: 25787093
[TBL] [Abstract][Full Text] [Related]
40. HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.
Bateman AC; Turner SJ; Theaker JM; Howell WM
Tissue Antigens; 1998 Jul; 52(1):67-73. PubMed ID: 9714476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
